|
|||||
|
|
Safety and immunogenicity of a modified-vaccinia-virus-Ankara-based influenza A H5N1 vaccine: a randomised,double-blind phase 1/2a clinical trial |
|
| Authors: | Joost H C M Kreijtz Marco Goeijenbier Fleur M Moesker Lennert van den Dries Simone Goeijenbier Heidi L M De Gruyter Michael H Lehmann Gerrie de Mutsert David A M C van de Vijver Asisa Volz Ron A M Fouchier Eric C M van Gorp Guus F Rimmelzwaan Gerd Sutter Albert D M E Osterhaus |
| Affiliation: | 1. Viroscience Lab, Erasmus Medical Center, Rotterdam, Netherlands;2. Institute for Infectious Diseases and Zoonoses, Ludwig Maximilian University of Munich, Munich, Germany;3. German Centre for Infection Research, Munich, Germany;4. Artemis, Utrecht, Netherlands;5. Center for Infection Medicine and Zoonoses Research, University of Veterinary Medicine, Hannover, Germany |
| Abstract: | |
| Keywords: | |
| 本文献已被 ScienceDirect 等数据库收录！ | |